SpectraGenetics LLC (Spectra) is a biotechnology company focused on the development and commercialization of technology for the molecular analysis of gene and transcript sequences. Spectra was founded with intellectual property and other assets acquired from Sequel Genetics Incorporated. The company's core technology is a proprietary gene-tagging method called Peptide Mass Signature Genotyping (PMSG) that has particular advantages for analyzing nucleic acids extracted from tumor samples. The company produces several products for research and pharaceutical development use including custom gene tagging, gene screening, and full length reporter tagged genes.
